Ribozymes used for restenosis prevention

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/713 (2006.01) A61K 48/00 (2006.01) A61P 9/10 (2006.01) A61P 41/00 (2006.01) C12N 9/00 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2385228

The invention relates to a catalytically active RNA molecule that is directed to mRNA molecules that encode the cell cycle relevant proteins cyclin E or E2F1. The catalytically active RNA molecule is a hammerhead ribozyme that induces the inhibition of the cell cycle of vascular smooth muscle cells in order to prevent restenosis.

Molécule d'ARN à action catalytique, qui est dirigée contre des molécules d'ARNm codant pour les protéines cycline E ou E2F1 pertinentes pour le cycle cellulaire. Ladite molécule d'ARN à action catalytique est un ribozyme en tête de marteau qui induit l'inhibition du cycle cellulaire de cellules vasculaires de muscles lisses pour prévenir la resténose.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ribozymes used for restenosis prevention does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ribozymes used for restenosis prevention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribozymes used for restenosis prevention will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1916945

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.